Pilot Evaluation to Assess the Clinical and Economic Impact of Pfizer's Pain Management Program (painPREMIER) in the Treatment of Low Back Pain, in an Occupational Health Care Setting in Finland

Pfizer

Status: Terminated

Conditions: Back Pain

Treatments: Other: painPREMIER cohort; Other: Control cohort

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT01787565

X9001016

Details and patient eligibility

About

The aim of this investigation is to determine whether the use of painPREMIER will significantly improve function in patients with low back pain in an occupational health clinical setting. painPREMIER is a tool that assists clinicians in the accurate diagnosis of back pain and associated problems in order to treat them most effectively.

Full description

Patients presenting at feeder sites to be referred to low back pain clinic and assessed for eligibility A decision was made to terminate this study on 09 OCT 2013. The study was terminated for operational/business reasons. This study was not terminated for reasons of safety or efficacy.

Enrollment: 86 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• New episode of low back pain
• Member of Terveystalo health insurance scheme

Exclusion criteria

• Previous back pain related healthcare visit in the last 3 months
• Patients identified as having a 'red flag' condition

Trial design

86 participants in 2 patient groups

painPREMIER cohort

Treatment:

Other: painPREMIER cohort

Control cohort

Treatment:

Other: Control cohort